Cardiol Therapeutics Inc. - COM CL A (CRDL)

Q4 2022 13F Holders as of 12/31/2022

Type / Class
Equity / COM CL A
Number of holders
27
Total Shares
5.64M
Shares change
+448K
Total reported value, excl. options
$2.89M
Value change
+$182K
Put/Call ratio
0.06
Number of buys
13
Number of sells
-8
Price
$0.51
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.